1. Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study. (December 2022) Authors: Yıldırım, Hasan Çağrı; Mutlu, Emel; Chalabiyev, Elvin; Özen, Miraç; Keskinkılıç, Merve; Ön, Sercan; Çelebi, Abdussamet; Dursun, Bengü; Acar, Ömer; Kahraman, Seda; Aykan, Musa Barış; Kaman, Ömür; Doğan, Akif; Erdoğan, Atike Pınar; Melisa Celayir, Özde; Günenç, Damla; Güven, Deniz Can; Vedat Bayoğl... Journal: Breast Issue: Volume 66(2022) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunotherapy-induced granulomatous reaction in patients with melanoma. Issue 4 (22nd June 2022) Authors: Taskaynatan, Halil; Gunenc, Damla; Ön, Sercan; Mizrak, Ali; Samancilar, Ozgur; Karaca, Burcak Journal: Melanoma research Issue: Volume 32:Issue 4(2022) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗